Posted on 12/7/18
Boston Scientific Corporation (BSX) Management on Citi's 2018 Global Healthcare Conference Call (Transcript)
Boston Scientific Corporation (NYSE:BSX) Citi's 2018 Global Healthcare Conference Call December 6, 2018 9:30 AM ETExecutivesArthur Butcher - SVP & President, EndoscopySusan Lisa - IRAnalystsAmit Hazan . . .
Posted on 12/7/18
Moderna Prices IPO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines . . .
Posted on 12/6/18
CloudHealth Unveils "Partner of the Year" Award Winners
CloudHealth, the trusted cloud management provider which is now part of VMware, today revealed its annual Partner of the Year award recipients as it celebrated a . . .
Posted on 12/6/18
121nexus Announces Rebrand to "Soom"
121nexus, a pioneer in utilizing barcode technology to bridge information gaps between data sources and physical products, announces today its new company name, Soom. Through the . . .
Posted on 12/6/18
BlueRock Therapeutics Strengthens Collaboration with the McEwen Stem Cell Institute
BlueRock Therapeutics, LP, an engineered cell therapy company leveraging its novel Cell+Gene platform to develop regenerative medicines for intractable diseases, announced today the strengthening of its . . .
Posted on 12/6/18
Can Celgene and bluebird bio Survive a Two-Pronged Attack?
Around this time last year, investors were thrilled with bluebird bio (NASDAQ:BLUE), and a next-generation cancer therapy that the pre-commercial biotech is developing in partnership with . . .
Posted on 12/5/18
Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific platform focused on discovering and developing . . .
Posted on 12/5/18
Peak Physical Therapy & Sports Performance Launches New Return-to-Sports Program at the University Sports Complex in Hanover
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provide comprehensive treatment in orthopedic, spine and sports medicine specialties, is . . .
Posted on 12/5/18
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that, on December . . .
Posted on 12/5/18
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to five new employees for an . . .
Posted on 12/5/18
Innovate Biopharmaceuticals Enters into a Collaboration with Massachusetts General Hospital
RALEIGH, N.C., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and . . .
Posted on 12/4/18
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (Nasdaq:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible factor (HIF), . . .
Posted on 12/4/18
Selecta Biosciences Announces New Employment Inducement Grants
WATERTOWN, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies . . .
Posted on 12/3/18
IFM Scientific Founders Named Among World's Most Influential Researchers
IFM Therapeutics, LLC (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system to treat inflammatory disorders . . .
Posted on 12/3/18
LogicBio Reports Third Quarter 2018 Financial Results
CAMBRIDGE, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC) (LogicBio or the Company), a genome editing company focused on developing medicines to durably . . .
Posted on 12/3/18
Ocular Therapeutix Announces FDA Approval of DEXTENZA for the Treatment of Ocular Pain Following Ophthalmic Surgery
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the . . .
Posted on 12/3/18
Biogen Outlook For The 2020s
SummaryCurrent therapies are driving revenue growth of 12% y/y.RNA-based therapy collaboration with Ionis should generate more Spinraza-like wins.Neurological disease pipeline is broad and will likely drive . . .
Posted on 12/3/18
Better Buy: Vertex Pharmaceuticals vs. Regeneron Pharmaceuticals
Ascending and descending? That might be how some investors view Vertex Pharmaceuticals(NASDAQ:VRTX) and Regeneron Pharmaceuticals (NASDAQ:REGN), respectively.Vertex made less than half the revenue that Regeneron did . . .
Posted on 12/3/18
Why Cara Therapeutics Is Up 50% in 2018
Cara Therapeutics (NASDAQ:CARA) enjoyed a really good year in 2017, with the stock jumping 32%. But the clinical-stage biotech is having a great year so far . . .
Posted on 12/2/18
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, granted equity awards on November . . .
Posted on 11/29/18
Davis Malm Attorney Robert J. Munnelly, Jr. Presents at MSCPA’s South Shore Breakfast Forum
Robert J. Munnelly, Jr. On November 15, Robert J. Munnelly, Jr., a shareholder at Boston law firm Davis, Malm & D'Agostine, presented at the Mass Society . . .
Posted on 11/29/18
Voyager Therapeutics Enters into Strategic Manufacturing Collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies
CAMBRIDGE, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological . . .
Posted on 11/29/18
AMAG Pharmaceuticals Awards Four Grants to Further Research in Preterm Birth and Preeclampsia
WALTHAM, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- As part of the company’s annual grant program to support research to reduce preterm birth and preeclampsia and . . .
Posted on 11/29/18
Pulmatrix Announces $3.0 Million Registered Direct Offering
Pulmatrix, Inc. (NASDAQ: PULM) today announced that it has entered into a securities purchase agreement with an institutional investor, providing for the purchase and sale of 9,375,000 . . .
Posted on 11/29/18
TCR2 Therapeutics wins U.S. Private Company of the Year Award at LifeStars Awards Life Sciences 2018 Event
TCR2 Therapeutics Inc., an innovative immunotherapy company developing the next generation of novel T cell receptor therapies for patients suffering from cancer, is pleased to announce . . .

